ORUKA THERAPEUTICS INC. - COMMON STOCK

12,19

24-января-25 14:59:49

15 мин. задержка

Акции

-0,28

-2,25%

Сегодняшний диапазон

12,05 - 12,89

ISIN

N/A

Источник

NASDAQ

Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, its Novel Half-life Extended Anti-IL-23p19 Antibody

19 дек 2024 06:00:00 Источник Nasdaq GlobeNewswire
Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)

18 дек 2024 06:00:00 Источник Nasdaq GlobeNewswire
Oruka Therapeutics to Present at Piper Sandler’s 36th Annual Healthcare Conference

19 ноя 2024 07:00:00 Источник Nasdaq GlobeNewswire
Oruka Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

13 ноя 2024 15:25:13 Источник Nasdaq GlobeNewswire
Oruka Therapeutics to Present at Multiple November Investor Conferences

04 ноя 2024 06:00:00 Источник Nasdaq GlobeNewswire
Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology Congress

25 сен 2024 06:08:51 Источник Nasdaq GlobeNewswire
Oruka Therapeutics Announces $200 Million Private Placement

12 сен 2024 06:05:00 Источник Nasdaq GlobeNewswire
Oruka Therapeutics Announces Accelerated Clinical Timelines and Upcoming Presentation at EADV Supporting ORKA-001’s Profile as a Potentially Best-in-Class Half-Life Extended Antibody Targeting IL-23p19

12 сен 2024 06:00:00 Источник Nasdaq GlobeNewswire
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million

03 сен 2024 06:00:00 Источник Nasdaq GlobeNewswire

<<
<
1
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.